Stockholder rights investigation

Search documents
TELIX ALERT: Bragar Eagel & Squire, P.C. is Investigating Telix Pharmaceuticals Limited on Behalf of Telix Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-08-23 13:36
Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Telix Pharmaceuticals Limited for possible violations of federal securities laws and unlawful business practices [1][2]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Telix to contact them to discuss their legal rights [1]. - On July 22, 2025, Telix received a subpoena from the U.S. Securities and Exchange Commission regarding disclosures related to its prostate cancer therapeutic candidates [2]. - Following the subpoena news, Telix's American Depositary Receipt (ADR) price dropped by $1.70, or 10.44%, closing at $14.58 per ADR on July 23, 2025 [2]. Group 2: Contact Information - Investors can reach out to Bragar Eagel & Squire for more information about the claims or their rights without any cost or obligation [3]. - Contact details for the law firm include phone number (212) 355-4648 and email investigations@bespc.com [6].
NATIONAL GRID INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Launches Investigation into National Grid plc on Behalf of National Grid Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-08-20 20:25
Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against National Grid plc for possible violations of federal securities laws and unlawful business practices following a fire incident at Heathrow Airport linked to the company's electrical substation [2][3]. Group 1: Incident Overview - On March 20, 2025, a fire at Heathrow Airport led to its shutdown, caused by a known fault at an electrical substation owned by National Grid, which the company had been aware of since 2018 but failed to address [3]. - Following the incident, Heathrow Airport is reportedly considering legal action against National Grid [3]. Group 2: Market Reaction - The news of the fire and its implications resulted in a decline in National Grid's American Depositary Receipt (ADR) price, which fell by $3.77, or 5.07%, closing at $70.61 per ADR on July 2, 2025 [4]. Group 3: Legal Action and Investor Outreach - Bragar Eagel & Squire, P.C. is reaching out to National Grid stockholders who may have suffered losses, encouraging them to discuss their legal rights and options [1][5]. - The law firm emphasizes that there is no cost or obligation for investors to inquire about their rights regarding these matters [5].
NATIONAL GRID ALERT: Bragar Eagel & Squire, P.C. Launches Investigation into National Grid plc on Behalf of National Grid Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-07-16 23:46
Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against National Grid plc for possible violations of federal securities laws and unlawful business practices following a fire incident at Heathrow Airport linked to the company [2][3]. Group 1: Incident Overview - On July 1, 2025, the National Energy System Operator published a report indicating that a fire at Heathrow Airport on March 20, 2025, was caused by a known fault at an electrical substation owned by National Grid, which had been aware of the issue since 2018 but did not address it [3]. - Following the report, Heathrow Airport is reportedly considering legal action against National Grid [3]. Group 2: Market Reaction - The news of the incident and subsequent investigation led to a decline in National Grid's American Depositary Receipt (ADR) price, which fell by $3.77, or 5.07%, closing at $70.61 per ADR on July 2, 2025 [4]. Group 3: Legal Representation - Bragar Eagel & Squire, P.C. is reaching out to National Grid stockholders who may have suffered losses and encourages them to discuss their legal rights [1][5].
PETMED ALERT: Bragar Eagel & Squire, P.C. is Investigating PetMed Express, Inc. on Behalf of PetMed Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-06-27 01:00
Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against PetMed Express, Inc. for possible violations of federal securities laws and unlawful business practices [1]. Group 1: Company Announcement - On June 10, 2025, PetMed announced a delay in the release of its fourth quarter and fiscal year 2025 earnings due to the need for additional time to complete the year-end audit process [2]. - Following this announcement, PetMed's stock price dropped by $0.47 per share, or 11.22%, closing at $3.72 per share on June 11, 2025 [2]. Group 2: Legal Investigation - The law firm is reaching out to PetMed stockholders who may have suffered losses and are interested in learning more about potential claims [3]. - The firm emphasizes that there is no cost or obligation for stockholders to inquire about their rights or interests regarding these matters [3]. Group 3: Law Firm Background - Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California, representing individual and institutional investors in various types of litigation [4].
BAUSCH & LOMB ALERT: Bragar Eagel & Squire, P.C. is Investigating Bausch + Lomb Corporation on Behalf of Bausch & Lomb Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-06-27 01:00
Core Viewpoint - Bausch + Lomb Corporation is under investigation for potential violations of federal securities laws and unlawful business practices following a product recall and subsequent stock price drop [1][2]. Group 1: Product Recall and Impact - On March 27, 2025, Bausch + Lomb announced a voluntary recall of intraocular lenses from its enVista platform due to reports of toxic anterior segment syndrome (TASS), which is a complication associated with cataract surgery [2]. - The recall has raised short-term concerns regarding product safety and may lead to increased regulatory scrutiny [2]. - Following the recall announcement, Bausch + Lomb's stock price fell by $1.50 per share, representing a 10.6% decrease, closing at $15.00 on the same day [2]. Group 2: Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Bausch + Lomb on behalf of its stockholders, focusing on possible violations of federal securities laws [1]. - The law firm is reaching out to long-term stockholders who may have suffered losses or have information related to the claims [3].
ICHOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Ichor Holdings, Ltd.
GlobeNewswire News Room· 2025-05-31 01:00
Core Viewpoint - Ichor Holdings, Ltd. is under investigation for potential violations of federal securities laws and unlawful business practices following disappointing financial results in Q1 2025, which led to a significant drop in stock price [1][2]. Financial Performance - On May 5, 2025, Ichor reported its Q1 2025 financial results, missing both EPS and revenue consensus estimates [2]. - The company reported a gross margin of 12.4%, which is below the forecasted midpoint of 14.5% [2]. - Ichor attributed the margin shortfall to purchasing more external supply than anticipated, which did not translate into expected margin flow [2]. Legal Investigation - Bragar Eagel & Squire, P.C. is investigating potential claims against Ichor on behalf of stockholders who may have suffered losses [1][3]. - The investigation focuses on whether Ichor has engaged in unlawful business practices or violated federal securities laws [1].
IOVANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Iovance Biotherapeutics, Inc. on Behalf of Iovance Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-14 01:00
Group 1 - Iovance Biotherapeutics reported a significant decline in first quarter 2025 product revenue, totaling $49.3 million compared to $73.7 million in the previous quarter [2] - The company revised its full fiscal year 2025 total product revenue guidance from a range of $450 million - $475 million to $250 million - $300 million, indicating a reduction of over 40% at the midpoint [2] - The revenue guidance revision was attributed to recent launch dynamics of the T cell immunotherapy, Amtagvi® (lifileucel), which was launched in the U.S. in the first half of 2024 [2] Group 2 - Following the announcement of the financial results and guidance revision, Iovance's stock experienced a drop on unusually heavy trading volume [2] - Bragar Eagel & Squire, P.C. is investigating potential claims against Iovance on behalf of stockholders regarding possible violations of federal securities laws and unlawful business practices [1]
BACKBLAZE ALERT: Bragar Eagel & Squire, P.C. is Investigating Backblaze, Inc. on Behalf of Backblaze Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire News Room· 2025-05-01 01:00
Core Viewpoint - Backblaze, Inc. is under investigation for potential violations of federal securities laws and unlawful business practices following a negative report from Morpheus Research that highlighted financial missteps and questionable accounting practices [1][2]. Group 1: Investigation and Legal Actions - Bragar Eagel & Squire, P.C. is investigating potential claims against Backblaze on behalf of its stockholders [1]. - The investigation is focused on whether Backblaze has engaged in unlawful business practices and violated federal securities laws [1]. - Stockholders who have suffered losses or have information regarding these claims are encouraged to contact the law firm [3]. Group 2: Financial Performance and Market Reaction - Backblaze's stock experienced a significant decline following the release of a critical report from Morpheus Research, which detailed alleged financial missteps since the company's IPO in November 2021 [2]. - The report accused Backblaze of questionable accounting practices, including financial manipulations and inflated forecasts [2]. - The stock price dropped during intraday trading on April 24, 2025, in response to the report [2].